Results 41 to 50 of about 473,800 (339)

KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update.

American Journal of Kidney Diseases, 2015
The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (KDOQI) has provided evidence-based guidelines for all stages of chronic kidney disease (CKD) and related complications since 1997. The 2015 update of the KDOQI Clinical Practice
M. Rocco, J. Daugirdas, T. Depner, Jula K. Inrig, Rajnish Mehrotra, M. Rocco, R. Suri, D. Weiner, N. Greer, A. Ishani, R. Macdonald, C. Olson, I. Rutks, Yelena Slinin, T. Wilt, H. Kramer, M. Choi, M. Samaniego‐Picota, P. Scheel, K. Willis, J. Joseph, L. Brereton   +21 more
semanticscholar   +1 more source

Halothane hepatitis with renal failure treated with hemodialysis and exchange transfusion [PDF]

, 1974
A 38-year-old white female, hepatitis B antigen negative, developed fluminating hepatic failure associated with oliguria and severe azotemia after two halothane anesthesia and without exposure to other hepatotoxic drugs or blood transfusions.
A. G. Redeker, B. Castleman, C. Trey, F. J. Tornetta, F. M. T. Carney, J. E. Kiley, J. G. Weg, Makoto Ishikawa, Mordecai M. Popovtzer, R. L. Peters, S. Sherlock, Shunzaburo Iwatsuki, Thomas E. Starzl, Torben Johansen, W. M. Keynes   +14 more
core   +1 more source

Different Effects of Low Weight Molecular Heparin and Unfractioned Heparin on Lipid Profile and Coagulation at Haemodialysis Patients

Biomolecules & Biomedicine, 2010
Each haemodialysis treatment requires the application of anticoagulation medicines, which will prevent coagulation in extracorporal blood circulation. In this study we try to determine the quality of admitted anticoagulant and his effect on lipid profile
Halima Resić, Nihad Kukavica, Vahidin Šahović, Fahrudin Masnić   +3 more
doaj   +1 more source

SARS-CoV-2–specific Humoral and Cellular Immunities in Kidney Transplant Recipients and Dialyzed Patients Recovered From Severe and Nonsevere COVID-19

Transplantation Direct, 2021
Background. Kidney transplantation and dialysis are two major risk factors for severe forms of coronavirus disease 2019 (COVID-19). The dynamics of the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in this population ...
Dominique Bertrand, MD, Mouad Hamzaoui, MD, PhD, Laurent Drouot, PhD, Julie Lamulle, MA, Mélanie Hanoy, MD, Stéphane Edet, MD, Charlotte Laurent, MD, Ludivine Lebourg, MD, Isabelle Etienne, MD, Mathilde Lemoine, MD, Frank Le Roy, MD, Dorian Nezam, MD, Eleusis Mauger, MD, Olivier Boyer, MD, PhD, Dominique Guerrot, MD, PhD, Sophie Candon, MD, PhD   +15 more
doaj   +1 more source

Reactions to synthetic membranes dialyzers: Is there an increase in incidence? [PDF]

, 2019
Background: Reactions to dialyzers used in dialysis have been reported more frequently in recent years. Evidence, however, shows that the reaction rate has remained stable for years.
Carriazo, Sol, Castillo, Emeralda, Esteras, Raquel, Fernández Prado, Raúl, González Parra, Emilio, Gracia Iguacel, Carolina, Martín Navarro, Juan, Mas Fontao, Sebastian, Ortiz, Alberto   +8 more
core   +2 more sources

Towards zero liquid discharge in hemodialysis. Possible issues

Nefrología (English Edition), 2021
Scarcity of water and energy, and legal requirements for discharge of waste and wastewater are forcing hemodialysis facilities to change their approach to a more integrated concept of connecting the residual output (in terms of waste, wastewater and ...
Faissal Tarrass, Omar Benjelloun, Meryem Benjelloun   +2 more
doaj   +2 more sources

Hemodialysis membrane-related neutrophil dysfunctions and pentoxifylline - a pilot study [PDF]

, 1990
Hemodialysis treatment is associated with activation of neutrophil granulocytes. Pentoxifylline has been shown to inhibit neutrophil activation in vitro and in vivo.
Hoffmann, H., Jochum, Marianne, Schiffl, H., Spannagl, Michael   +3 more
core   +1 more source

Clinical Factors Associated With Pneumocystis Pneumonia Despite Its Primary Prophylaxis: When to Stop Prophylaxis?

Arthritis &Rheumatology, EarlyView.
Objective Although previous studies show that primary prophylaxis against Pneumocystis jirovecii pneumonia (PJP) is effective in patients with rheumatic diseases receiving immunosuppressive treatment, there is limited evidence regarding the optimal timing for prophylaxis withdrawal.
Ju Yeon Kim, Se Rim Choi, Jin Kyun Park, Eun Young Lee, Eun Bong Lee, Jun Won Park   +5 more
wiley   +1 more source

The tacrolimus concentration‐to‐dose ratio is associated with kidney function in heart transplant recipients

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Heart transplantation (HT) is frequently complicated by chronic kidney disease, of which tacrolimus‐related nephrotoxicity is an important cause. In kidney and liver transplant recipients, fast tacrolimus metabolism (defined as a low concentration‐to‐dose [C0/D] ratio), negatively affects kidney function.
Maaike R. Schagen, Teun B. Petersen, Boris C. A. Seijkens, Jasper J. Brugts, Kadir Caliskan, Alina A. Constantinescu, Brenda C. M. de Winter, Isabella Kardys, Dennis A. Hesselink, Olivier Manintveld   +9 more
wiley   +1 more source

Hepatitis C in hemodialysis centers of golestan province, northeast of Iran (2005) [PDF]

, 2008
Background and Aims: Nosocomial transmission of blood-borne pathogens is common in a dialysis setting. Hepatitis C virus (HCV) infection is a common problem that increases morbidity and mortality in hemodialysis patients.
Besharat, S., Jabbari, A., Khodabakshi, B.   +2 more
core